litlas
Log inCreate account

Britta Weigelt

Active 2002–2026

252
Papers
34,196
Citations
99
h-index
235
i10-index

Citations

Citations per year for Britta Weigelt1926: 1 citations1985: 1 citations1993: 1 citations1994: 1 citations1996: 1 citations1998: 1 citations2002: 1 citations2003: 6 citations2004: 32 citations2005: 71 citations2006: 110 citations2007: 146 citations2008: 177 citations2009: 182 citations2010: 293 citations2011: 282 citations2012: 242 citations2013: 204 citations2014: 285 citations2015: 339 citations2016: 380 citations2017: 432 citations2018: 432 citations2019: 1,276 citations2020: 1,441 citations2021: 1,450 citations2022: 1,162 citations2023: 1,021 citations2024: 1,602 citations2025: 868 citations2026: 33 citations1927–1984: no citations, so these years are not shown1986–1992: no citations, so these years are not shown1995: no citations, so this year is not shown1997: no citations, so this year is not shown1999–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,450 citing papers, 26.9% of this breakdownChina: 1,816 citing papers, 11% of this breakdownUnited Kingdom: 1,163 citing papers, 7.1% of this breakdownItaly: 929 citing papers, 5.6% of this breakdownGermany: 713 citing papers, 4.3% of this breakdownFrance: 627 citing papers, 3.8% of this breakdownCanada: 624 citing papers, 3.8% of this breakdownSpain: 545 citing papers, 3.3% of this breakdownNetherlands: 500 citing papers, 3% of this breakdownAustralia: 430 citing papers, 2.6% of this breakdownJapan: 378 citing papers, 2.3% of this breakdownSwitzerland: 349 citing papers, 2.1% of this breakdown
0%26.9%Other 24.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology46.8%
  • Medicine45.3%
  • Immunology and Microbiology2.2%
  • Engineering1.8%
  • Computer Science1.6%
  • Materials Science0.5%
  • Other1.8%

Topics

  • Cancer Genomics and Diagnostics7.2%
  • Cancer Cells and Metastasis4.3%
  • Breast Cancer Treatment Studies3.9%
  • HER2/EGFR in Cancer Research2.2%
  • Cancer Immunotherapy and Biomarkers2.2%
  • Endometrial and Cervical Cancer Treatments2.1%
  • Other78.1%

Coauthors

All papers

Open in search
  1. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Mark T.A. Donoghue, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. Iacobuzio–Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - Cell 2022 cited by 663

  2. Diverse alterations associated with resistance to KRAS(G12C) inhibition

    Authors: Yulei Zhao, Yonina R. Murciano‐Goroff, Jenny Y. Xue, Agnes Ang, Jessica Lucas, Trang T. Mai, Arnaud Da Cruz Paula, Anne Y. Saiki, Deanna Mohn, Pragathi Achanta, Ann Elizabeth Sisk, Kanika Arora, Rohan S. Roy, Dong-Sung Kim, Chuanchuan Li, Lee P. Lim, Mark Li, Amber Bahr, Brian Houck‐Loomis, Elisa de Stanchina, Jorge S. Reis-Filho, Britta Weigelt, Michael F. Berger, Gregory J. Riely, Kathryn C. Arbour, J. Russell Lipford, Bob T. Li, Piro Lito - Nature 2021 cited by 447

  3. The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

    Authors: Pedram Razavi, Matthew T. Chang, Guotai Xu, Chaitanya Bandlamudi, Dara S. Ross, Neil Vasan, Yanyan Cai, Craig M. Bielski, Mark T.A. Donoghue, Philip Jonsson, Alexander Penson, Ronglai Shen, Fresia Pareja, Ritika Kundra, Sumit Middha, Michael L. Cheng, Ahmet Zehir, Cyriac Kandoth, Ruchi Patel, Kety Huberman, Lillian M. Smyth, Komal Jhaveri, Shanu Modi, Tiffany A. Traina, Chau T. Dang, Wen Zhang, Britta Weigelt, Bob T. Li, Marc Ladanyi, David M. Hyman, Nikolaus Schultz, Mark E. Robson, Clifford A. Hudis, Edi Brogi, Agnès Viale, Larry Norton, Maura N. Dickler, Michael F. Berger, Christine A. Iacobuzio–Donahue, Sarat Chandarlapaty, Maurizio Scaltriti, Jorge S. Reis‐Filho, David B. Solit, Barry S. Taylor, José Baselga - Cancer Cell 2018 cited by 1,006

  4. Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer

    Authors: Isaac García-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte K.Y. Ng, Sarah Hrebien, Rosalind Cutts, Maggie C.U. Cheang, Peter Osin, Ashutosh Nerurkar, Iwanka Kozarewa, Javier Armisen Garrido, Mitch Dowsett, Jorge S. Reis‐Filho, Ian E. Smith, Nicholas C. Turner - Science Translational Medicine 2015 cited by 1,132

  5. Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma

    Authors: Leticia De Mattos‐Arruda, Regina Mayor, Charlotte K.Y. Ng, Britta Weigelt, Francisco Martínez‐Ricarte, Davis Y. Torrejon, Mafalda Oliveira, Alexandra Arias, C. Raventós, Jiabin Tang, Elena Guerini‐Rocco, Elena Martínez‐Sáez, Sergio Lois, Óscar Marín, Xavier de la Cruz, Salvatore Piscuoglio, Russel Towers, Ana Vivancos, Vicente Peg, Santiago Ramón y Cajal, Joan Carles, Jordi Rodón, María González‐Cao, Josep Tabernero, Enriqueta Felip, Juan Sahuquillo, Michael F. Berger, Javier Cortés, Jorge S. Reis‐Filho, Joan Seoane - Nature Communications 2015 cited by 858

  6. Ovarian cancer mutational processes drive site-specific immune evasion

    Authors: Ignacio Vázquez-Garćıa, Florian Uhlitz, Nicholas Ceglia, Jamie Lim, Michelle Wu, Neeman Mohibullah, Juliana Niyazov, Arvin Ruiz, Kevin Boehm, Viktoria Bojilova, Christopher J. Fong, Tyler Funnell, Diljot Grewal, Eliyahu Havasov, Samantha Leung, Arfath Pasha, Druv Patel, Maryam Pourmaleki, Nicole Rusk, Hongyu Shi, R. Vanguri, Marc Williams, Allen W. Zhang, Vance Broach, S. Dennis, Arnaud Da Cruz Paula, Ginger J. Gardner, Sarah H. Kim, Matthew Lennon, Kara Long Roche, Yukio Sonoda, Oliver Zivanovic, Ritika Kundra, Agnès Viale, Fatemeh Derakhshan, Luke Geneslaw, Shirin Issa Bhaloo, Ana Maroldi, Rahelly Nunez, Fresia Pareja, Anthe A. Stylianou, Mahsa Vahdatinia, Yonina Bykov, Rachel N. Grisham, Ying L. Liu, Yulia Lakhman, Ines Nikolovski, Daniel J. Kelly, Jianjiong Gao, Andrea Schietinger, Travis J. Hollmann, Samuel F. Bakhoum, Robert A. Soslow, Lora H. Ellenson, Nadeem R. Abu‐Rustum, Carol Aghajanian, Claire F. Friedman, Andrew McPherson, Britta Weigelt, Dmitriy Zamarin, Sohrab P. Shah - Nature 2022 cited by 307

  7. Breast cancer metastasis: markers and models

    Authors: Britta Weigelt, Johannes L. Peterse, Laura J. van’t Veer - Nature reviews. Cancer 2005 cited by 2,247

  8. Single-cell genomic variation induced by mutational processes in cancer

    Authors: Tyler Funnell, Ciara H. O’Flanagan, Marc Williams, Andrew McPherson, Steven McKinney, Farhia Kabeer, Hakwoo Lee, Sohrab Salehi, Ignacio Vázquez-Garćıa, Hongyu Shi, Emily Leventhal, Tehmina Masud, Peter Eirew, Damian Yap, Allen W. Zhang, Jamie Lim, Beixi Wang, Jazmine Brimhall, Justina Biele, Jerome Ting, Vinci Au, Michael Van Vliet, Yifei Liu, Sean Beatty, Daniel Lai, Jenifer Pham, Diljot Grewal, Douglas N. Abrams, Eliyahu Havasov, Samantha Leung, Viktoria Bojilova, Richard A. Moore, Nicole Rusk, Florian Uhlitz, Nicholas Ceglia, Adam C. Weiner, Elena Zaikova, J. Maxwell Douglas, Dmitriy Zamarin, Britta Weigelt, Sarah H. Kim, Arnaud Da Cruz Paula, Jorge S. Reis‐Filho, Spencer D. Martin, Yangguang Li, Hongxia Xu, Teresa Ruiz de Algara, So Ra Lee, Viviana Cerda Llanos, David G. Huntsman, Jessica N. McAlpine, Gregory J. Hannon, Georgia Battistoni, Dario Bressan, Ian G. Cannell, Hannah Casbolt, Cristina Jauset, Tatjana Kovačević, Claire M. Mulvey, Fiona Nugent, Marta Ribes, Isabella Pearson, Fatime Qosaj, Kirsty Sawicka, Sophia A. Wild, Elena Williams, Emma Laks, Austin Smith, Daniel Lai, Andrew Roth, Shankar Balasubramanian, Maximilian Lee, Bernd Bodenmiller, Marcel Burger, Laura Kuett, Sandra Tietscher, Jonas Windhager, Edward S. Boyden, Shahar Alon, Yi Cui, Amauche Emenari, Daniel Goodwin, Emmanouil D. Karagiannis, Anubhav Sinha, Asmamaw T. Wassie, Carlos Caldas, Alejandra Bruna, Maurizio Callari, Wendy Greenwood, Giulia Lerda, Yaniv Eyal-Lubling, Oscar M. Rueda, Abigail Shea, Owen Harris, Robby Becker, Flaminia Grimaldo, Suvi Harris, Sara Lisa Vogl, Johanna A. Joyce, Spencer S. Watson and 20 more - Nature 2022 cited by 152

  9. Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging

    Authors: Evis Sala, Eralda Mema, Yuki Himoto, Harini Veeraraghavan, James D. Brenton, Alexandra Snyder, Britta Weigelt, H. Alberto Vargas - Clinical Radiology 2016 cited by 358

  10. Epigenetic dysregulation from chromosomal transit in micronuclei

    Authors: Albert S. Agustinus, Duaa H. Al-Rawi, Bhargavi Dameracharla, Ramya Raviram, Bailey S.C.L. Jones, Stephanie Stransky, Lorenzo Scipioni, Jens Luebeck, Melody Di Bona, Danguolė Norkūnaitė, Robert M. Myers, Mercedes A. Duran Paez, Seongmin Choi, Britta Weigelt, Shira Yomtoubian, Andrew McPherson, Eléonore Toufektchan, Kristina Keuper, Paul S. Mischel, Vivek Mittal, Sohrab P. Shah, John Maciejowski, Zuzana Štorchová, Enrico Gratton, Peter Ly, Dan A. Landau, Mathieu F. Bakhoum, Richard P. Koche, Simone Sidoli, Vineet Bafna, Yael David, Samuel F. Bakhoum - Nature 2023 cited by 115

  11. Molecular Characterization of Acquired Resistance to KRASG12C–EGFR Inhibition in Colorectal Cancer

    Authors: Rona Yaeger, Riccardo Mezzadra, Jenna Sinopoli, Yu Bian, Michelangelo Marasco, Esther Kaplun, Yijun Gao, HuiYong Zhao, Arnaud Da Cruz Paula, Yingjie Zhu, Almudena Chaves Perez, Kalyani Chadalavada, Edison Tse, Sudhir Chowdhry, Sydney Bowker, Qing Chang, Besnik Qeriqi, Britta Weigelt, Gouri J. Nanjangud, Michael F. Berger, Hirak Der‐Torossian, Kenna Anderes, Nicholas D. Socci, Jinru Shia, Gregory J. Riely, Yonina R. Murciano‐Goroff, Bob T. Li, James G. Christensen, Jorge S. Reis‐Filho, David B. Solit, Elisa de Stanchina, Scott W. Lowe, Neal Rosen, Sandra Misale - Cancer Discovery 2022 cited by 138

  12. Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

    Authors: Alejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager, Simon Koplev, Oliver Cast, Dominique‐Laurent Couturier, Danish Memon, Pier Selenica, Ines Nikolovski, Yousef Mazaheri, Yonina Bykov, Felipe C. Geyer, Geoff Macintyre, Lena Morrill Gavarró, Ruben M. Drews, Michael B. Gill, Anastasios D. Papanastasiou, Ramon E. Sosa, Robert A. Soslow, Tyler Walther, Ronglai Shen, S. Dennis, Kay J. Park, Travis J. Hollmann, Jorge S. Reis‐Filho, Florian Markowetz, Pedro Beltrão, Hebert Alberto Vargas, Dmitriy Zamarin, James D. Brenton, Alexandra Snyder, Britta Weigelt, Evis Sala, Martin L. Miller - Nature Genetics 2020 cited by 253

  13. Classification of endometrial carcinoma: more than two types

    Authors: Rajmohan Murali, Robert A. Soslow, Britta Weigelt - The Lancet Oncology 2014 cited by 663

  14. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Authors: Bastien Nguyen, Christopher J. Fong, Anisha Luthra, Shaleigh Smith, Renzo G. DiNatale, Subhiksha Nandakumar, Henry Walch, Walid K. Chatila, Ramyasree Madupuri, Ritika Kundra, Craig M. Bielski, Brooke Mastrogiacomo, Adrienne Boire, Sarat Chandarlapaty, Karuna Ganesh, James J. Harding, Christine A. lacobuzio-Donahue, Pedram Razavi, Ed Reznik, Charles M. Rudin, Dmitriy Zamarin, Wassim Abida, Ghassan K. Abou‐Alfa, Carol Aghajanian, Andrea Cercek, Ping Chi, Darren R. Feldman, Alan L. Ho, Gopa Iyer, Yelena Y. Janjigian, Michael J. Morris, Robert J. Motzer, Eileen M. O’Reilly, Michael A. Postow, Nitya Raj, Gregory J. Riely, Mark E. Robson, Jonathan E. Rosenberg, Anton Safonov, Alexander N. Shoushtari, William D. Tap, Min Yuen Teo, Anna M. Varghese, Martin H. Voss, Rona Yaeger, Marjorie G. Zauderer, Nadeem R. Abu‐Rustum, Julio García‐Aguilar, Bernard H. Bochner, A. Ari Hakimi, William R. Jarnagin, David R. Jones, Daniela Molena, Luc G.T. Morris, Eric Rios‐Doria, Paul Russo, Samuel Singer, Vivian E. Strong, Debyani Chakravarty, Lora H. Ellenson, Anuradha Gopalan, Jorge S. Reis‐Filho, Britta Weigelt, Marc Ladanyi, Mithat Gönen, Sohrab P. Shah, Joan Massagué, Jianjiong Gao, Ahmet Zehir, Michael F. Berger, David B. Solit, Samuel F. Bakhoum, Francisco Sánchez-Vega, Nikolaus Schultz - 2021 cited by 69

  15. Immunogenicity and therapeutic targeting of a public neoantigen derived from mutated PIK3CA

    Authors: Smita S. Chandran, Jiaqi Ma, Martin G. Klatt, Friederike Dündar, Chaitanya Bandlamudi, Pedram Razavi, Hannah Y. Wen, Britta Weigelt, Paul Zumbo, Si Ning Fu, Lauren B. Banks, Fei Yi, Enric Vercher, Iñaki Etxeberría, Watchain D. Bestman, Arnaud Da Cruz Paula, Ilinca Aricescu, Alexander Drilon, Doron Betel, David A. Scheinberg, Brian M. Baker, Christopher A. Klebanoff - Nature Medicine 2022 cited by 129

  16. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy

    Authors: Robert Samstein, Chirag Krishna, Xiaoxiao Ma, Xin Pei, Ken-Wing Lee, Vladimir Makarov, Fengshen Kuo, Jonathan Chung, Raghvendra M. Srivastava, Tanaya A. Purohit, Douglas R. Hoen, Rajarsi Mandal, Jeremy Setton, Wei Wu, Rachna Shah, Besnik Qeriqi, Qing Chang, Sviatoslav M. Kendall, Lior Z. Braunstein, Britta Weigelt, Pedro Blecua, Luc G.T. Morris, Diana Mandelker, Jorge S. Reis‐Filho, Elisa de Stanchina, Simon N. Powell, Timothy A. Chan, Nadeem Riaz - Nature Cancer 2020 cited by 210

  17. Diverse BRCA1 and BRCA2 Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

    Authors: Britta Weigelt, Iñaki Comino‐Méndez, Ino de Bruijn, Lei Tian, Jane Meisel, Isaac García-Murillas, Charlotte Fribbens, Ros Cutts, Luciano G. Martelotto, Charlotte K.Y. Ng, Raymond S. Lim, Pier Selenica, Salvatore Piscuoglio, Carol Aghajanian, Larry Norton, Rajmohan Murali, David M. Hyman, Laetitia Borsu, Maria E. Arcila, Jason Konner, Jorge S. Reis‐Filho, Roger A. Greenberg, Mark E. Robson, Nicholas C. Turner - Clinical Cancer Research 2017 cited by 258

  18. Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

    Authors: Eric Rios‐Doria, Amir Momeni Boroujeni, Claire F. Friedman, Pier Selenica, Qin Zhou, Michelle Wu, Antonio Marra, Mario M. Leitão, Alexia Iasonos, Kaled M. Alektiar, Yukio Sonoda, Vicky Makker, Elizabeth L. Jewell, Ying L. Liu, Dennis Chi, Dimitry Zamarin, Nadeem R. Abu‐Rustum, Carol Aghajanian, Jennifer J. Mueller, Lora H. Ellenson, Britta Weigelt - Gynecologic Oncology 2023 cited by 88

  19. Histological types of breast cancer: How special are they?

    Authors: Britta Weigelt, Felipe C. Geyer, Jorge S. Reis‐Filho - Molecular Oncology 2010 cited by 558

  20. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle

    Authors: Leticia De Mattos‐Arruda, Britta Weigelt, Javier Cortés, Helen Won, Charlotte K.Y. Ng, Paolo Nucíforo, François‐Clément Bidard, Claudia Aura, Cristina Saura, Vicente Peg, Salvatore Piscuoglio, Mafalda Oliveira, Yvonne H. C. M. Smolders, Pragi Patel, Larry Norton, Josep Tabernero, Michael F. Berger, Joan Seoane, Jorge S. Reis‐Filho - Annals of Oncology 2014 cited by 378

  21. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

    Authors: Allen S. Ho, Angelica Ochoa, Gowtham Jayakumaran, Ahmet Zehir, Cristina Valero Mayor, Justin Tepe, Vladimir Makarov, Martin G. Dalin, Jie He, Mark Bailey, Meagan Montesion, Jeffrey S. Ross, Vincent A. Miller, Lindsay Chan, Ian Ganly, Snjezana Doğan, Nora Katabi, Petros Tsipouras, Patrick K. Ha, Nishant Agrawal, David B. Solit, P. Andrew Futreal, Adel K. El Naggar, Jorge S. Reis‐Filho, Britta Weigelt, Alan L. Ho, Nikolaus Schultz, Timothy A. Chan, Luc G.T. Morris - Journal of Clinical Investigation 2019 cited by 210

  22. Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

    Authors: Kelly L. Bolton, Denise Chen, Rosario I. Corona, Zhuxuan Fu, Rajmohan Murali, Martin Köbel, Yanis Tazi, Julie M. Cunningham, Irenaeus C.C. Chan, Brian Wiley, Lea A. Moukarzel, Stacey J. Winham, Sebastian M. Armasu, Jenny Lester, Esther Elishaev, Angela Laslavic, Catherine J. Kennedy, Anna Piskorz, Magdalena Sekowska, Alison H. Brand, Yoke-Eng Chiew, Paul D.P. Pharoah, Kevin M. Elias, Ronny Drapkin, Michael Churchman, Charlie Gourley, Anna DeFazio, Beth Y. Karlan, James D. Brenton, Britta Weigelt, Michael S. Anglesio, David G. Huntsman, Simon A. Gayther, Jason Konner, Francesmary Modugno, Kate Lawrenson, Ellen L. Goode, Elli Papaemmanuil - Clinical Cancer Research 2022 cited by 103

  23. Activation of the IFN Signaling Pathway is Associated with Resistance to CDK4/6 Inhibitors and Immune Checkpoint Activation in ER-Positive Breast Cancer

    Authors: Carmine De Angelis, Xiaoyong Fu, Maria Letizia Cataldo, Agostina Nardone, Resel Pereira, Jamunarani Veeraraghavan, Sarmistha Nanda, Lanfang Qin, Vidyalakshmi Sethunath, Tao Wang, Susan G. Hilsenbeck, Matteo Benelli, Ilenia Migliaccio, Cristina Guarducci, Luca Malorni, Lacey M. Litchfield, Jiangang Liu, Joshua Donaldson, Pier Selenica, David N. Brown, Britta Weigelt, Jorge S. Reis‐Filho, Ben Ho Park, Sara A. Hurvitz, Dennis J. Slamon, Mothaffar F. Rimawi, Valerie M. Jansen, Rinath Jeselsohn, C. Kent Osborne, Rachel Schiff - Clinical Cancer Research 2021 cited by 94

  24. MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

    Authors: Beryl Manning-Geist, Sushmita Gordhandas, Ying L. Liu, Qin Zhou, Alexia Iasonos, Arnaud Da Cruz Paula, Diana Mandelker, Kara Long Roche, Oliver Zivanovic, Anna Maio, Yelena Kemel, Dennis S. Chi, Roisin E. O'Cearbhaill, Carol Aghajanian, Britta Weigelt, M. Herman Chui, Rachel N. Grisham - Clinical Cancer Research 2022 cited by 83